Cereblon (CRBN) is a substrate receptor of the E3 ubiquitin ligase complex that has been linked to autosomal recessive non-syndromic mental retardation. Several key findings suggest diverse roles of CRBN, including its regulation of the large-conductance calcium- and voltage-activated potassium (BKCa) channels, regulation of thalidomide-binding proteins, and mediation of lenalidomide treatment in multiple myeloma. Recent studies also indicate that CRBN is involved in energy metabolism and negatively regulates AMP-activated protein kinase signaling. Mice with genetic depletion of CRBN are resistant to various stress conditions including a high-fat diet, endoplasmic reticulum stress, ischemia/reperfusion injury, and alcohol-related liver dama...
Cereblon (CRBN), the substrate receptor of an E3 ubiquitin ligase complex, is a target of thalidomid...
Upon binding to thalidomide and other immunomodulatory drugs, the E3 ligase substrate receptor cereb...
Immunomodulatory drugs (IMiDs) are important for the treatment of multiple myeloma and myelodysplast...
Cereblon (CRBN) is a substrate receptor of the E3 ubiquitin ligase complex that has been linked to a...
Mutations in the cereblon (CRBN) gene cause human intellectual disability, one of the most common co...
The use of thalidomide derivatives (IMIDs) has improved multiple myeloma prognosis, through an unkno...
The discovery and implementation of immunomodulatory drugs (IMiD®s) has revolutionized the treatment...
AbstractMutations in cereblon (CRBN), a substrate binding component of the E3 ubiquitin ligase compl...
Intellectual disability (ID), one of the most common human developmental disorders, can be caused by...
Intellectual disability (ID), one of the most common human developmental disorders, can be caused by...
Thalidomide analogues (or immunomodulatory imide drugs, IMiDs) are cornerstones in the treatment of ...
Thalidomide is a teratogen that causes multiple malformations in the developing baby through its int...
Cereblon (CRBN), a substrate receptor for Cullin-ring E3 ubiquitin ligase (CRL), is a major target p...
Cereblon (CRBN) is a substrate receptor protein for the CRL4A E3 ubiquitin ligase complex. In this s...
Immunomodulatory drugs (IMiDs) are effective in the treatment of multiple myeloma (MM), myelodysplas...
Cereblon (CRBN), the substrate receptor of an E3 ubiquitin ligase complex, is a target of thalidomid...
Upon binding to thalidomide and other immunomodulatory drugs, the E3 ligase substrate receptor cereb...
Immunomodulatory drugs (IMiDs) are important for the treatment of multiple myeloma and myelodysplast...
Cereblon (CRBN) is a substrate receptor of the E3 ubiquitin ligase complex that has been linked to a...
Mutations in the cereblon (CRBN) gene cause human intellectual disability, one of the most common co...
The use of thalidomide derivatives (IMIDs) has improved multiple myeloma prognosis, through an unkno...
The discovery and implementation of immunomodulatory drugs (IMiD®s) has revolutionized the treatment...
AbstractMutations in cereblon (CRBN), a substrate binding component of the E3 ubiquitin ligase compl...
Intellectual disability (ID), one of the most common human developmental disorders, can be caused by...
Intellectual disability (ID), one of the most common human developmental disorders, can be caused by...
Thalidomide analogues (or immunomodulatory imide drugs, IMiDs) are cornerstones in the treatment of ...
Thalidomide is a teratogen that causes multiple malformations in the developing baby through its int...
Cereblon (CRBN), a substrate receptor for Cullin-ring E3 ubiquitin ligase (CRL), is a major target p...
Cereblon (CRBN) is a substrate receptor protein for the CRL4A E3 ubiquitin ligase complex. In this s...
Immunomodulatory drugs (IMiDs) are effective in the treatment of multiple myeloma (MM), myelodysplas...
Cereblon (CRBN), the substrate receptor of an E3 ubiquitin ligase complex, is a target of thalidomid...
Upon binding to thalidomide and other immunomodulatory drugs, the E3 ligase substrate receptor cereb...
Immunomodulatory drugs (IMiDs) are important for the treatment of multiple myeloma and myelodysplast...